David Owens
Chief Medical Officer, Director · Nexalin Technology, Inc.
- 2024
- Dec 23, 2025
- 4
Other insiders active in the same stocks
Insiders who have reported open-market trades at the same companies as David Owens. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Marilyn Elson - $403 in NXL purchases and sales on record
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is David Owens?
David Owens is a corporate insider, tracked as Chief Medical Officer, Director of Nexalin Technology, Inc. (NXL). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did David Owens last file a Form 4?
The most recent primary Form 4 on record is dated 23 December 2025, one of 4 filings going back to 2024.
Has David Owens been buying or selling stock?
Recorded transactions: 1 open-market purchase ($1K) and 0 open-market sales across all tracked filings.
